NCT00155259View on ClinicalTrials.gov

Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

December 31, 2006

Conditions
Breast Cancer
Interventions
DRUG

Docetaxel , Cisplatin , Capecitabine

Trial Locations (1)

Unknown

Department of Oncology, National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00155259 - Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter